NOTE TO THE FILE
Sent to TICRS as Serial Number: 88491698SERIAL NUMBER: 88491734
DATE: 09/23/2019
NAME: tbhupathi
NOTE:
Dear Tara:
Yes, please do the same for those cases. It is correct that the client did not sign the dec for TRUSIPVIA, so I will have to follow up with them for that as well. I will enter the attorney bar info when we file responses.
Thank you.
Regards,
Allison
Allison Strickland Ricketts | aricketts@fzlz.com
Fross Zelnick | 212.813.5967
From: Bhupathi, Tara [mailto:Tara.Bhupathi@USPTO.GOV]
Sent: Thursday, September 19, 2019 10:02 AM
To: Allison S. Ricketts <aricketts@fzlz.com>
Cc: Michelle Klein <mklein@fzlz.com>
Subject: RE: United States Trademark Application Serial No. 88491698 - ETRUVORT
Hi Allison,
Thank you for your quick response. I will issue a priority action for ETRUVORT. The same issue is present in 88491734 VELSIPITY and 88491765 TRUSIPVIA. Can I send a priority action for those two applications as well? For TRUSIPVIA, the application is not signed, so the PA would also include a declaration requirement. Please let me know your thoughts.
Thank you!
Tara
Tara L. Bhupathi
Examining Attorney
Law Office 124
(571) 272-5557
From: Allison S. Ricketts <aricketts@fzlz.com>
Sent: Wednesday, September 18, 2019 8:23 PM
To: Bhupathi, Tara <Tara.Bhupathi@USPTO.GOV>
Cc: Michelle Klein <mklein@fzlz.com>
Subject: RE: United States Trademark Application Serial No. 88491698 - ETRUVORT
Dear Ms. Bhupathi:
Please issue a priority action.
Thank you.
Regards,
Allison
Allison Strickland Ricketts | aricketts@fzlz.com
Fross Zelnick | 212.813.5967
From: Bhupathi, Tara [mailto:Tara.Bhupathi@USPTO.GOV]
Sent: Wednesday, September 18, 2019 11:32 AM
To: Ricketts Docket <ricketts-docket@fzlz.com>
Subject: Re: United States Trademark Application Serial No. 88491698 - ETRUVORT
United States Trademark Application Serial No. 88491698 - ETRUVORT
Dear Ms. Ricketts,
I am the assigned trademark examining attorney for the above-referenced application. The application should be ready to proceed once applicant agrees to modify the identification of goods. If the changes below are acceptable, I will issue an examiner's amendment accordingly:
Class 5: Pharmaceutical preparations for human use to treat {indicate purpose/function/use for the goods}; Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
Please let me know by phone or email if you agree to allow me to correct the above by an examiner's amendment or if you have any questions about the application.
Kind regards,
Tara L. Bhupathi
Examining Attorney
Law Office 124
(571) 272-5557
The information contained in this email message may be privileged, confidential, and protected from disclosure. Any unauthorized use, printing, copying, disclosure or dissemination of this communication may be subject to legal restriction or sanction. If you think that you have received this email message in error, please reply to the sender.